CIvsHCA
Cigna GroupvsHCA Healthcare Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Cigna Group
$279.72
+1.31%
HCA Healthcare Inc
$474.03
+0.46%
60-day price, rebased to 100
Round-by-round
Valuation upside
+961.30% vs +55.10% to DCF fair value
Balance-sheet strength
Altman Z 2.53 vs 2.75
Fundamental quality
Piotroski 7.00 vs 7.00 (of 9)
Growth + margins
Rule-of-40 15.50 vs 17.30
60-day momentum
+2.05% vs -4.59% price return
Market-cap liquidity
$71.2B vs $105.5B
Verdict
Across6categories,HCAtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onCIorHCA
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.